Animal experiments-an essential component for the development of liposomal anticancer agents.
Fichtner
Iduna
I
Max-Delbrück-Center for Molecular Medicine, Berlin-Buch, Germany.
Reszka
Regina
R
Arndt
Dieter
D
Zeisig
Reiner
R
D000818:Animals; D000830:Animals, Laboratory; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D016190:Carboplatin / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D002626:Chemistry, Pharmaceutical; D004353:Drug Evaluation, Preclinical; D005260:Female; D008081:Liposomes / Q000008:administration & dosage* / Q000737:chemistry; D051379:Mice; D013629:Tamoxifen / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics
D000970:Antineoplastic Agents; D008081:Liposomes; D013629:Tamoxifen; D016190:Carboplatin